AMAG Pharmaceuticals Shares outstanding
What is the Shares outstanding of AMAG Pharmaceuticals?
The Shares outstanding of AMAG Pharmaceuticals, Inc. is 34.725M
What is the definition of Shares outstanding?
Shares outstanding are all the shares of a corporation or of a financial asset that have been authorized, issued and purchased by investors and are held by them.
= issued shares - treasury shares
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Shares outstanding of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with shares outstanding similar to AMAG Pharmaceuticals
- Star L.P has Shares outstanding of 34.661M
- Artemis Alpha Trust plc has Shares outstanding of 34.663M
- Universal Cables has Shares outstanding of 34.695M
- Universal Cables has Shares outstanding of 34.695M
- SMA Solar Technology AG has Shares outstanding of 34.700M
- Marine Products Corp has Shares outstanding of 34.718M
- AMAG Pharmaceuticals has Shares outstanding of 34.725M
- Valhalla Metals has Shares outstanding of 34.732M
- AVEO Pharmaceuticals Inc has Shares outstanding of 34.763M
- Urban One Inc has Shares outstanding of 34.773M
- Watsco has Shares outstanding of 34.789M
- Hunter Douglas NV has Shares outstanding of 34.790M
- Full House Resorts has Shares outstanding of 34.800M